Differential ischemic stroke risk linked to novel subtypes of type 2 diabetes: insights from a Mendelian randomization analysis
- PMID: 38691263
- DOI: 10.1007/s12020-024-03842-z
Differential ischemic stroke risk linked to novel subtypes of type 2 diabetes: insights from a Mendelian randomization analysis
Abstract
Purpose: This study employs a two-sample Mendelian randomization (MR) approach to investigate the variation in ischemic stroke risk across novel subtypes of adult-onset type 2 diabetes.
Methods: Leveraging pooled genome-wide association study (GWAS) data from the Swedish ANDIS cohort, we explored the association of four newly identified type 2 diabetes subtypes-severe insulin-deficient diabetes (SIDD), severe insulin-resistant diabetes (SIRD), mild obesity-related diabetes (MOD), and mild age-related diabetes (MARD)-with ischemic stroke risk. The outcome data for ischemic stroke and its three subtypes (large artery, cardioembolic, and small vessel stroke) were sourced from the MEGASTROKE Consortium. Our analysis applied multiple MR methods, focusing on the inverse-variance weighted (IVW) technique, complemented by thorough sensitivity analyses to examine heterogeneity and potential horizontal pleiotropy.
Results: Our findings reveal a significant causal relationship between the SIDD subtype and small vessel stroke (OR = 1.06, 95% CI: 1.01-1.11, p = 0.025), while no causal associations were observed for SIRD with any stroke subtype. MOD was causally linked to small vessel stroke (OR = 1.07, 95% CI: 1.02-1.12, p = 0.004) and large artery stroke (OR = 1.07, 95% CI: 1.01-1.13, p = 0.015). Similarly, MARD showed a causal relationship with small vessel stroke (OR = 1.09, 95% CI: 1.03-1.16, p = 0.006) and overall ischemic stroke risk (OR = 1.04, 95% CI: 1.01-1.08, p = 0.010).
Conclusions: Our study highlights distinct causal links between specific type 2 diabetes subtypes and ischemic stroke risks, emphasizing the importance of subtype-specific prevention and treatment strategies.
Keywords: Diabetes; Epidemiology; Ischemic stroke; Mendelian randomization.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Causal effects and mediating pathways of metabolic dysfunction-associated fatty liver disease on novel subtypes of adult-onset diabetes: A two-step Mendelian randomization study.Nutr Metab Cardiovasc Dis. 2025 Jun;35(6):103976. doi: 10.1016/j.numecd.2025.103976. Epub 2025 Mar 11. Nutr Metab Cardiovasc Dis. 2025. PMID: 40180825
-
Genetically proxied appendicular lean mass and stroke risk: A two-step mendelian randomization study.J Stroke Cerebrovasc Dis. 2024 Oct;33(10):107915. doi: 10.1016/j.jstrokecerebrovasdis.2024.107915. Epub 2024 Aug 2. J Stroke Cerebrovasc Dis. 2024. PMID: 39098364
-
Causal associations between gut microbiota and type 2 diabetes mellitus subtypes: a mendelian randomization analysis.BMC Endocr Disord. 2025 Mar 24;25(1):79. doi: 10.1186/s12902-025-01863-x. BMC Endocr Disord. 2025. PMID: 40122799 Free PMC article.
-
The role of mitochondrial DNA copy number in cardiometabolic disease: a bidirectional two-sample mendelian randomization study.Cardiovasc Diabetol. 2024 Jan 28;23(1):45. doi: 10.1186/s12933-023-02074-1. Cardiovasc Diabetol. 2024. PMID: 38282013 Free PMC article. Review.
-
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.Circulation. 2019 Jan 8;139(2):256-268. doi: 10.1161/CIRCULATIONAHA.118.035905. Circulation. 2019. PMID: 30586705 Free PMC article. Review.
Cited by
-
Mendelian randomization studies on ischemic stroke: a field synopsis and systematic review.J Transl Med. 2025 Aug 22;23(1):955. doi: 10.1186/s12967-025-06992-4. J Transl Med. 2025. PMID: 40847399 Free PMC article. Review.
References
-
- D. Kuriakose, Z. Xiao, Pathophysiology and treatment of stroke: present status and future perspectives. Int. J. Mol. Sci. 21, 7609 (2020). https://doi.org/10.3390/ijms21207609 - DOI - PubMed - PMC
-
- E.S. Donkor, Stroke in the 21st century: a snapshot of the burden, epidemiology, and quality of life. Stroke Res. Treat. 2018, 3238165 (2018). https://doi.org/10.1155/2018/3238165 - DOI - PubMed - PMC
-
- H.S. Markus, Stroke genetics. Hum. Mol. Genet. 20, R124–131 (2011). https://doi.org/10.1093/hmg/ddr345 - DOI - PubMed
-
- M. Traylor, M. Farrall, E.G. Holliday, C. Sudlow, J.C. Hopewell, Y.-C. Cheng, M. Fornage, M.A. Ikram, R. Malik, S. Bevan, U. Thorsteinsdottir, M.A. Nalls, W. Longstreth, K.L. Wiggins, S. Yadav, E.A. Parati, A.L. DeStefano, B.B. Worrall, S.J. Kittner, M.S. Khan, A.P. Reiner, A. Helgadottir, S. Achterberg, I. Fernandez-Cadenas, S. Abboud, R. Schmidt, M. Walters, W.-M. Chen, E.B. Ringelstein, M. O’Donnell, W.K. Ho, J. Pera, R. Lemmens, B. Norrving, P. Higgins, M. Benn, M. Sale, G. Kuhlenbäumer, A.S.F. Doney, A.M. Vicente, H. Delavaran, A. Algra, G. Davies, S.A. Oliveira, C.N.A. Palmer, I. Deary, H. Schmidt, M. Pandolfo, J. Montaner, C. Carty, P.I.W. de Bakker, K. Kostulas, J.M. Ferro, N.R. van Zuydam, E. Valdimarsson, B.G. Nordestgaard, A. Lindgren, V. Thijs, A. Slowik, D. Saleheen, G. Paré, K. Berger, G. Thorleifsson, A. Hofman, T.H. Mosley, B.D. Mitchell, K. Furie, R. Clarke, C. Levi, S. Seshadri, A. Gschwendtner, G.B. Boncoraglio, P. Sharma, J.C. Bis, S. Gretarsdottir, B.M. Psaty, P.M. Rothwell, J. Rosand, J.F. Meschia, K. Stefansson, M. Dichgans, H.S. Markus, Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a metaanalysis of genome-wide association studies. Lancet. Neurology. 11, 951–962 (2012). https://doi.org/10.1016/S1474-4422(12)70234-X - DOI - PubMed
-
- S.C. Larsson, A. Wallin, N. Håkansson, O. Stackelberg, M. Bäck, A. Wolk, Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases. Int. J. Cardiol. 262, 66–70 (2018). https://doi.org/10.1016/j.ijcard.2018.03.099 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical